Abstract
Accumulating evidence indicates that epithelial-to-mesenchymal transition (EMT), originally described as a key process for organ development and metastasis budding in cancer, plays a key role in the development of renal fibrosis in several diseases, including hypertensive nephroangiosclerosis. We herein reviewed the concept of EMT and its role in renal diseases, with particular focus on hypertensive kidney disease, the second leading cause of end-stage renal disease after diabetes mellitus. After discussing the pathophysiology of hypertensive nephropathy, the ‘classic’ view of hypertensive nephrosclerosis entailing hyalinization, and sclerosis of interlobular and afferent arterioles, we examined the changes occurring in the glomerulus and tubulo-interstitium and the studies that investigated the role of EMT and its molecular mechanisms in hypertensive kidney disease. Finally, we examined the reasons why some studies failed to provide solid evidence for renal EMT in hypertension.
Author supplied keywords
Cite
CITATION STYLE
Seccia, T., Caroccia, B., Piazza, M., & Rossi, G. P. (2019, July 2). The Key Role of Epithelial to Mesenchymal Transition (EMT) in Hypertensive Kidney Disease. International Journal of Molecular Sciences. MDPI AG. https://doi.org/10.3390/ijms20143567
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.